The Benefits of Immediate ART
The benefits of “early” antiretroviral therapy (ART; ie, initiation when CD4 ≥500 cells/mm 3 ) are now well accepted as reflected in the removal of the CD4-based eligibility from new ART guidelines by the World Health Organization (WHO). However, neither the “treat-all” strategy recommendations pres...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-03-01
|
Series: | Journal of the International Association of Providers of AIDS Care |
Online Access: | https://doi.org/10.1177/2325958219831714 |